Addressing the management of atrial fibrillation &ndash; a systematic review of the role of dronedarone | Zendy

Gian Marco Podda | Zendy; Giovanni Casazza | Zendy; Casella | Zendy; Franca Dipaola | Zendy; Scannella | Zendy; Tagliabue | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Addressing the management of atrial fibrillation – a systematic review of the role of dronedarone

Author(s) -

Gian Marco Podda,

Giovanni Casazza,

Casella,

Franca Dipaola,

Scannella,

Tagliabue

Publication year - 2012

Publication title -

international journal of general medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.722

H-Index - 36

ISSN - 1178-7074

DOI - 10.2147/ijgm.s16674

Subject(s) - dronedarone , medicine , atrial fibrillation , management of atrial fibrillation , intensive care medicine , cardiology , pharmacology , amiodarone

Atrial fibrillation (AF) is the most common sustained arrhythmia. It occurs in 1%-2% of the general population and its prevalence increases with age. Dronedarone, a noniodinated benzofuran similar to amiodarone, was developed as an antiarrhythmic agent for patients with atrial fibrillation. The aim of our systematic review was to critically evaluate randomized controlled trials that compared treatment with dronedarone versus placebo or amiodarone in patients with atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research